Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katie Thoren
Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) May Result in ATG Overexposure That Negatively Affects Outcomes
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Cell Transplantation After Failed Autologous Transplant for Lymphoma Using TLI and Anti-Thymocyte Globulin Conditioning
Bone Marrow Transplantation
Transplantation
Hematology
Clinical Outcomes of Matched Unrelated Allogeneic Stem Cell Transplant Patients: Low Dose ATG vs. No ATG
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Successful Allogeneic Hematopoietic Cell Transplantation Using Flu-Bu-Atg Conditioning for “Mono-Mac Syndrome” [GATA2 Deficiency]
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Co-Infections by Double-Stranded DNA Viruses After Ex Vivo T Cell–Depleted, CD34 + Selected Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Early Fluid Overload Is a Serious Toxicity Associated With an Increased Risk of Non-Relapse Mortality After Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
DNA Virus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
